PHAR logo

Pharming Group NV (PHAR) Accounts Payable

Annual Accounts Payable

$16.02 M
+$7.27 M+83.05%

31 December 2023

PHAR Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$72.64 M
-$329.00 K-0.45%

30 September 2024

PHAR Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PHAR Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+83.0%+16.1%
3 y3 years+18.9%+72.3%
5 y5 years+110.9%+93.8%

PHAR Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+110.8%-0.5%+855.9%
5 y5 years-60.6%+110.9%-0.5%+855.9%
alltimeall time-60.6%+1342.4%-0.5%+6439.3%

Pharming Group NV Accounts Payable History

DateAnnualQuarterly
Sept 2024
-
$72.64 M(-0.5%)
June 2024
-
$72.97 M(+6.5%)
Mar 2024
-
$68.52 M(+327.6%)
Dec 2023
$16.02 M(+83.0%)
$16.02 M(-74.4%)
Sept 2023
-
$62.54 M(+5.5%)
June 2023
-
$59.30 M(+11.4%)
Mar 2023
-
$53.25 M(+508.4%)
Dec 2022
$8.75 M(+15.2%)
$8.75 M(-79.5%)
Sept 2022
-
$42.74 M(-5.2%)
June 2022
-
$45.07 M(+10.4%)
Mar 2022
-
$40.83 M(+437.3%)
Dec 2021
$7.60 M(-43.6%)
$7.60 M(-82.0%)
Sept 2021
-
$42.15 M(-2.3%)
June 2021
-
$43.14 M(-1.1%)
Mar 2021
-
$43.60 M(+223.7%)
Dec 2020
$13.47 M(-66.9%)
$13.47 M(-66.9%)
Sept 2020
-
$40.65 M(-14.3%)
June 2020
-
$47.41 M(+0.9%)
Mar 2020
-
$46.99 M(+15.6%)
Dec 2019
$40.65 M(+435.0%)
$40.65 M(+8.4%)
Sept 2019
-
$37.49 M(+12.0%)
June 2019
-
$33.47 M(+14.2%)
Mar 2019
-
$29.31 M(+285.7%)
Dec 2018
$7.60 M(-32.8%)
$7.60 M(-79.0%)
Sept 2018
-
$36.22 M(+17.1%)
June 2018
-
$30.93 M(-13.4%)
Mar 2018
-
$35.71 M(+215.7%)
DateAnnualQuarterly
Dec 2017
$11.31 M(+90.3%)
$11.31 M(-43.4%)
Sept 2017
-
$20.00 M(+16.5%)
June 2017
-
$17.16 M(-4.9%)
Mar 2017
-
$18.04 M(+203.5%)
Dec 2016
$5.94 M(+435.1%)
$5.94 M(-45.5%)
Sept 2016
-
$10.90 M(-3.9%)
June 2016
-
$11.34 M(+7.8%)
Mar 2016
-
$10.52 M(+846.6%)
Dec 2015
$1.11 M(-69.0%)
$1.11 M(-87.6%)
Sept 2015
-
$8.98 M(-0.9%)
June 2015
-
$9.06 M(-2.6%)
Mar 2015
-
$9.30 M(+159.9%)
Dec 2014
$3.58 M(-35.6%)
$3.58 M(-51.9%)
Sept 2014
-
$7.45 M(+66.3%)
June 2014
-
$4.48 M(-54.3%)
Mar 2014
-
$9.79 M(+76.1%)
Dec 2013
$5.56 M(+273.4%)
$5.56 M(+16.7%)
Sept 2013
-
$4.76 M(+34.0%)
June 2013
-
$3.56 M(-38.2%)
Mar 2013
-
$5.75 M(+286.4%)
Dec 2012
$1.49 M(-43.9%)
$1.49 M(-80.3%)
Sept 2012
-
$7.56 M(+184.8%)
Dec 2011
$2.65 M(-76.7%)
$2.65 M(-72.0%)
June 2010
-
$9.47 M(-16.0%)
Mar 2010
-
$11.28 M
Dec 2007
$11.42 M(+13.6%)
-
Dec 2006
$10.05 M
-

FAQ

  • What is Pharming Group NV annual accounts payable?
  • What is the all time high annual accounts payable for Pharming Group NV?
  • What is Pharming Group NV annual accounts payable year-on-year change?
  • What is Pharming Group NV quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Pharming Group NV?
  • What is Pharming Group NV quarterly accounts payable year-on-year change?

What is Pharming Group NV annual accounts payable?

The current annual accounts payable of PHAR is $16.02 M

What is the all time high annual accounts payable for Pharming Group NV?

Pharming Group NV all-time high annual accounts payable is $40.65 M

What is Pharming Group NV annual accounts payable year-on-year change?

Over the past year, PHAR annual accounts payable has changed by +$7.27 M (+83.05%)

What is Pharming Group NV quarterly accounts payable?

The current quarterly accounts payable of PHAR is $72.64 M

What is the all time high quarterly accounts payable for Pharming Group NV?

Pharming Group NV all-time high quarterly accounts payable is $72.97 M

What is Pharming Group NV quarterly accounts payable year-on-year change?

Over the past year, PHAR quarterly accounts payable has changed by +$10.10 M (+16.15%)